Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
CABAZITAXEL
Jevtana
Prostate Cancer
LPS14022PRIMCABNCT02379390Tabulated Results
CABAZITAXEL
Jevtana
Prostate Cancer
LPS14201CARDNCT02485691Tabulated Results
CABAZITAXEL
Jevtana
Neoplasms, malignant
POP12251NANCT01527929Summary
CABAZITAXEL
Jevtana
Neoplasms, malignant
POP6792NANCT01140607Summary
CABAZITAXEL
Jevtana
Neoplasms, Malignant
TCD11068NANCT01001221Tabulated Results
CABAZITAXEL
Jevtana
Prostate Cancer
TCD12128NANCT01511536Tabulated Results
CABAZITAXEL
Jevtana
Prostate Cancer, Hormone Refractory
TED11576NANCT01324583Summary
CABAZITAXEL
Jevtana
Solid Tumors
TED12689NANCT01751308Tabulated Results
CAPECITABINE/CYCLOPHOSPHAMIDE
Not marketed
Breast Cancer Metastatic
CAPCYR07568METRO-ABCNCT02664103Summary
CAPLACIZUMAB
Cablivi
Unstable Angina; Non ST Segment Elevation Myocardial Infarction (NSTEMI); Stable Angina (Associated With High Risk PCI)
ALX-0081-2.1/09NANCT01020383Summary

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted